Distribution of hepatitis C virus genotypes, hepatic steatosis and their correlation with clinical and virological factors in Pakistan

1. Qadri I, Iwahashi M, Capasso JM, Hopken MW, Flores S, Schaack J, et al. Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: role of JNK, p38 MAPK and AP-1. Biochem J. 2004; 378: 919-8.10.1042/bj20031587Search in Google Scholar

2. Guo J,Yan R, Xu G, Li W, Zheng C. Construction of the Vero cell culture system that can produce infectious HCV particles. Mol Biol. Rep 2007; 36: 111-20.10.1007/s11033-007-9158-3Search in Google Scholar

3. Jose LW, Gutierrez JA, EllIman WB, Stump DD, Keller TR, Rodriguez A, et al. Mutation Master: Profiles of substitutions inhepatitis C virus RNA of the core, alternate reading frame, and NS2 coding regions. RNA. 2002; 8: 557-71.10.1017/S1355838202029023Search in Google Scholar

4. Ross RS, Viazov SO, Holtzer CD, Beyou A, Monnet A, Mazure C, et al. Genotyping of Hepatitis C Virus Isolates using CLIP Sequencing. J Clin Microbiol. 2000; 38: 3581-4.10.1128/JCM.38.10.3581-3584.2000Search in Google Scholar

5. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, et al. Detection of hepatitis C virus by polymerase chain reaction and response to inteterferon alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology. 1992; 16:293-9.10.1002/hep.1840160203Open DOISearch in Google Scholar

6. Kanai K, Kako M, Okamoto H. HCV genotypes in chronic hepatitis C virus and response to interferon. Lancet. 1992; 339:1543.10.1016/0140-6736(92)91311-USearch in Google Scholar

7. Shah H.A, Jafri W, Malik I, Prescott L, Simmonds P. Hepatitis C virus (HCV) genotypes and chronic liver disease in Pakistan. J Gastroenterol Hepatol. 1997; 12: 758-61.10.1111/j.1440-1746.1997.tb00366.x9430043Search in Google Scholar

8. Szanto P, Grigorescu M, Dumitru I, Serban A. Steatosis in hepatitis C virus infection. Response to anti-viral therapy. J Gastrointestin Liver Dis. 2006; 15:117-24Search in Google Scholar

9. Marzouk D, Sass J, Bakr I, Hosseiny ME, Hamid MA, Rekacewicz C, et al. Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt. Gut. 2007; 56:1105-10.10.1136/gut.2006.091983195551216956918Search in Google Scholar

10. Asselah T, Boyer N, Guimont MC, Hatem DC, Tubach F , Nahon K, et al . Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C. Gut. 2003; 52:1638-43.10.1136/gut.52.11.1638177387014570735Search in Google Scholar

11. Qadri I, Iwahashi M, Kullak-Ublick GA, Simon FR. Hepatocyte nuclear factor (HNF) 1 and HNF4 mediate hepatic multidrug resistance protein 2 Up-regulation during hepatitis C virus gene expression. Mol Pharmacol. 2006; 70: 627-36.10.1124/mol.106.02349916670373Open DOISearch in Google Scholar

12. Waris G, Felmlee DJ, Negro F, Siddiqui A. Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress. J Virol. 2007; 8: 8122-3.10.1128/JVI.00125-07195132017507484Search in Google Scholar

13. Yoon EJ, Hu KQ. Hepatitis C virus (HCV) infection and hepatic steatosis. Int J Med Sci. 2006; 3:53-6.10.7150/ijms.3.53Search in Google Scholar

14. Castera L, Chouteau P, Hezode C, Zafrani ES, Dhumeaux D, Pawlotsky JM. Hepatitis C virus-induced hepatocellular steatosis. Am J Gastroenterol. 2005; 100: 711-5.10.1111/j.1572-0241.2005.40898.x15743372Open DOISearch in Google Scholar

15. Gupte P, Dudhade A, desai HG. Acquired apolipoprotein B deficiency with chronic hepatitis C virus infection. Indian J Gasrtroenterol. 2006; 25: 311-2.Search in Google Scholar

16. Ohno T, Mizokami M, Wu RR, Saleh MG, Ohba KI, Orito E, et al. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol. 1997; 35: 201-7.10.1128/jcm.35.1.201-207.1997Search in Google Scholar

17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chemistry. 1972; 18: 499-502.10.1093/clinchem/18.6.499Search in Google Scholar

18. Waheed Y, Shafi T, Safi SZ, Qadri I. Hepatitis C virus in Pakistan: a review of prevalence, genotypes and risk factors. World J Gastroenterology. 2010; in press.10.3748/wjg.15.5647Search in Google Scholar

19. Romero-Gomez M, Castellano-Megias VM, Grande L, Irles JA, Cruz M, Nogales MC, et al. Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C. Am J Gastroenterol. 2003; 98: 1135-41.10.1016/S0002-9270(03)00185-0Search in Google Scholar

20. Rubbia-Brandt L, Fabris P, Paganin S, Leandro G, Male PJ, Giostra E. Steatosis affects chronic hepatitis C progression in a genotype specific way. Gut. 2004; 53: 406-12.10.1136/gut.2003.018770177398914960525Search in Google Scholar

21. Afridi S, Naeem M, Hussain A, Kakar N, Babar ME, Ahmad J. Prevalence of hepatitis C virus (HCV) genotypes in Balochistan. Mol Biol Rep. 2009; 36: 1511-4. 10.1007/s11033-008-9342-018766467Search in Google Scholar

22. Idrees M, Riazuddin S. Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infectious Diseases. 2008; 8:69.10.1186/1471-2334-8-69240934618498666Search in Google Scholar

23. Castera L, Chouteau P, Hezode C, Zafrani ES, Dhumeaux D, Pawlotsky JM. Hepatitis C virus induced hepatocellular steatosis. Am J Gastroenterol. 2005; 100: 711-5.10.1111/j.1572-0241.2005.40898.xOpen DOISearch in Google Scholar

24. Gordon A, McLean CA, Pedersen JS, Bailey MJ, Roberts SK. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis. J Hepatol. 2005; 43: 38-44.10.1016/j.jhep.2005.01.03115876468Open DOISearch in Google Scholar

25. Perlemuter G, Sabile A, Letteron P, Vona G, Topilco A, Chretien Y, et al: Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viralrelated steatosis. FASEB J. 2002, 16:185-94.10.1096/fj.01-0396com11818366Open DOISearch in Google Scholar

26. Shi ST, Polyak SJ, Tu H, Taylor DR, Gretch DR, Lai MM. Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins. Virology. 2002, 292:198-210.10.1006/viro.2001.122511878923Search in Google Scholar

27. Kumar D,Farrell GC, Fung C, George J. Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response. Hepatology. 2002; 36:1266-72.10.1053/jhep.2002.3637012395339Search in Google Scholar

28. Sabile A, Perlemuter G, Bono F, Kohara K, Demaugre F, Kohara M, et al. Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates. Hepatology. 1999; 30:1064-76.10.1002/hep.51030042910498661Search in Google Scholar

29. Tsutsumi T, Suzuki T, Shimoike T, Suzuki R, Moriya K, Shintani Y, et al. Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity. Hepatology. 2002; 35:937-46.10.1053/jhep.2002.3247011915042Open DOISearch in Google Scholar

30. Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology. 2002; 122:366-75.10.1053/gast.2002.3098311832451Search in Google Scholar

31. Kolwankar D, Vuppalanchi R, Ethell B, Jones DR, Wrighton SA, Hall SD, et al. Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity. Clin Gastroenterol Hepatol. 2007; 5: 388-93.10.1016/j.cgh.2006.12.02117368239Search in Google Scholar

32. Hourioux C, Patient R, Morin A, Blanchard E, Moreau A, trassard S, et al. The genotype 3-specific hepatitis c virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model. Gut. 2007; 56: 1302-8.10.1136/gut.2006.108647226737217213339Search in Google Scholar

33. Jackel-Cram C, Babiuk LA, Liu Q. Up-regulation of fatty acid synthase promoter by hepatitis C virus core protein: genotype-3a core has a stronger effect than genotype-1b core. J Hepatol. 2007; 46: 985-7.10.1016/j.jhep.2006.10.01917188392Search in Google Scholar

34. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology. 2002; 122: 1649-57.10.1053/gast.2002.3357312016429Search in Google Scholar

35. Guidi M, Muratori P, Granito A, Muratori L, Pappas G, Lenzi M, et al. Hepatic steatosis in chronic hepatitis C: impact on response to anti-viral treatment with peg-interferon and ribavirin. Aliment Pharmacol Ther. 2005; 22:943-9.10.1111/j.1365-2036.2005.02679.x16268968Search in Google Scholar